FDA Person
FDAMatthew B. Casale
View detailed information about Matthew B. Casale, including compliance records, violations, and related data.
Person Profile
FDA investigator. Took part in 92 inspections of 90 companies, 2016–2026.
Inspections (92)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| September 18, 2026 | Phyton Biotech LLC | Not classified | #1340750 | |
| September 11, 2026 | Labs-Mart Inc | Not classified | #1341114 | |
| July 24, 2026 | Boehringer Ingelheim Biopharmaceuticals (China) Ltd. | Not classified | #1330776 | |
| July 14, 2026 | Shenzhen Techdow Pharmaceutical Co., Ltd. | Not classified | #1329698 | |
| May 8, 2026 | Alvotech HF | Not classified | #1317238 | |
| April 27, 2026 | Similasan AG | Not classified | Drug Quality Assurance | #1313406 |
| February 27, 2026 | EUGIA Pharma Specialities Limited | Not classified | Drug Quality Assurance | #1304662 |
| December 12, 2025 | Apitoria Pharma Private Limited | Not classified | #1297984 | |
| November 28, 2025 | Glenmark Pharmaceuticals Limited | Not classified | #1298220 | |
| September 26, 2025 | Sichuan Xieli Pharmaceutical Co. Ltd. | Not classified | #1291276 | |
| September 19, 2025 | Huatai Biopharm Inc. | Not classified | #1288714 | |
| September 12, 2025 | Zhejiang Jinhua Conba Bio-pharm. Co., Ltd. (Jinxi) | Not classified | #1286104 | |
| August 22, 2025 | Noble Pharma, LLC | VAI | Pre-Approval Evaluation of Animal Drugs and Food Additives | #1280216 |
| July 18, 2025 | Sun Pharmaceutical Industries Limited- Madhuranthagam | Not classified | #1278809 | |
| July 11, 2025 | Anjan Drug Private Limited | Not classified | #1277816 | |
| July 4, 2025 | Par Active Technologies Private Limited | NAI | Drug Quality Assurance | #1277606 |
| May 9, 2025 | Solara Active Pharma Sciences Limited | NAI | Drug Quality Assurance | #1273116 |
| May 2, 2025 | Embio Limited | NAI | Drug Quality Assurance | #1272275 |
| April 25, 2025 | Kopran Research Laboratories Limited | NAI | Drug Quality Assurance | #1272141 |
| February 28, 2025 | Asanuma Corporation - Sagamihara Factory | VAI | Drug Quality Assurance | #1262199 |
Documents (47)
- 483 · COSMAX, INC. · October 18, 2024
- 483 · Ajinomoto Company Inc. · February 21, 2025
- 483 · Infusion Partners, LLC · January 26, 2018
- 483 · Gipsco Investment Corp · June 9, 2017
- 483 · Loop Plaza Pharmacy Company DBA Loop Compounding Pharmacy · December 16, 2016
- 483 · RC Compounding Services, LLC · February 16, 2018
- 483 · The Wellness Pharmacy · March 12, 2015
- EIR · Buderer Drug Company Inc · January 4, 2016
- 483 · Crosbys Drugs Inc · September 16, 2016
- 483 · EUGIA Pharma Specialities Limited · February 27, 2026
- 483 · RC Outsourcing, LLC · March 31, 2017
- 483 · Buderer Drug Company Inc · July 24, 2017
- 483 RESPONSE · Jeni's Splendid Ice Creams, LLC · April 30, 2015
- 483 · Buderer Drug Company Inc · January 4, 2016
- EIR · Fermic S.A. de C.V. · December 13, 2024
- EIR · North American Science Associates, LLC · October 6, 2015
- EIR · North American Science Associates, LLC · February 8, 2017
- 483 · Chunghwa Chemical Synthesis & Biotech Co., Ltd · November 14, 2022
- 483 · Alembic Pharmaceuticals Limited · August 30, 2022
- 483 · Ajinomoto Company Inc. · February 17, 2025
- 483 · Intas Pharmaceuticals Limited · June 8, 2018
- 483 · Samsung Biologics Co., Ltd. · November 1, 2019
- 483 · Asanuma Corporation - Sagamihara Factory · February 28, 2025
- 483 · Ricola Ag · February 18, 2022
- 483 · Spartan Chemical Co Inc · March 26, 2021
- 483 · Corium Innovations, Inc. · October 27, 2017
- 483 · Celltrion Inc. · October 22, 2019
- 483 · Shenzhen Oriental Pharmaceutical Co Ltd · January 7, 2019
- 483 · Corden Pharma Fribourg SA · February 3, 2023
- 483 · Takasago International Corporation · November 19, 2018
- 483 · Maropack AG · February 11, 2022
- 483 · Noble Pharma, LLC · August 22, 2025
- 483 · Infusion Partners, LLC · January 26, 2018
- 483 · Hot Shots Nm, LLC · August 9, 2019
- 483 · BioChem Sioux City Inc. · August 6, 2021
- 483 · Apitoria Pharma Private Limited · December 1, 2025
- 483 · Steri-Med Pharma Inc. · February 27, 2024
- 483 · Zhejiang Jiuzhou Pharmaceutical Co., Ltd. · September 10, 2018
- 483 · Chemblend of America LLC · June 7, 2024
- 483 · Yakult Honsha Co., Ltd. · November 12, 2018
- 483 · AqVida GmbH · June 3, 2022
- 483 · Englewood Lab Korea Co., Ltd. · October 25, 2024
- 483 · Similasan AG · April 27, 2026
- 483 · Qilu Pharmaceutical Co., Ltd. (Dongjia Site) · June 12, 2023
- 483 · Alvotech HF · May 8, 2026
- 483 · Merck Biodevelopment
- 483 · Alembic Pharmaceuticals Limited · August 30, 2022
Person Information
Name
Matthew B. Casale
Title
Investigator
Role
Regulatory Personnel
ID: e78481c6-5fbd-4723-a79c-167176395af8
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.